# Atara Biotherapeutics, Inc.: Form 8-K, filed Sep 28, 2022

- Company: [Atara Biotherapeutics, Inc.](/companies/atra.md) (CIK 1604464)
- Form: 8-K
- Filed: 2022-09-28
- Accepted by EDGAR: Sep 28, 2022, 16:30 ET
- Period: 2022-09-28
- Accession: 0001193125-22-253304
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1604464/000119312522253304/d389266d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1604464/000119312522253304/

## Items reported

- Item 1.01: Entry into a material agreement

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1604464/000119312522253304/d389266d8k.htm

Filed Sep 28, 2022.
Source: SEC EDGAR, the filing index for accession 0001193125-22-253304. Last ingested by Listed: Nov 11, 2026, 02:48 ET. No prices; not investment advice.
